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ABSTRACT
We studied the impact of bariatric surgery on the intestinal microbiota of morbidly
obese study subjects. A total of 13 morbidly obese women (five of which had type 2
diabetes) and 14 healthy age- and gender-matched controls were recruited and the
microbiota composition of fecal samples were determined by using a phylogenetic
microarray. Sampling of the patients took place just one month before and 6 months
after the operation. Within six months after bariatric surgery, the obese subjects had
lost on average a quarter of their weight whereas four of the five of the diabetic
subjects were in remission. Bariatric surgery was associated with an increased microbial
community richness and Bacteroidetes/Firmicutes ratio. In addition, we observed an
increased relative abundance of facultative anaerobes, such as Streptococcus spp., and
a reduction in specific butyrate-producing Firmicutes. The observed postoperative
alterations in intestinal microbiota reflect adaptation to the changing conditions in the
gastrointestinal tract, such as energy restriction and the inability to process fiber-rich
foods after bariatric surgery.
Subjects Microbiology, Clinical Trials, Diabetes and Endocrinology, Nutrition, Metabolic
Sciences
Keywords Fecal microbiota, Bariatric surgery, Type 2 diabetes, Obesity, Clinical trial
INTRODUCTION
The global obesity epidemic is still worsening affecting a total of 603.7 million adults and
107.7 million children with ominous implications for both physical and economic health
(Collaborators GBDO et al., 2017). Several studies have shown that intestinal microbes
contribute to the regulation of energy homeostasis, fat storage, and energy uptake, and
are likely to play a role in obesity and its complications (Karlsson et al., 2013; Kootte et al.,
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2012; Krajmalnik-Brown et al., 2012). Indeed, the intestinal microbiota signatures, such as
altered composition as well as reduction in taxonomic diversity and functional richness
have been associated with obesity (Cotillard et al., 2013; Turnbaugh et al., 2009) and several
experimental studies have shown a causal link between obesity and gut microbiota (Liou
et al., 2013; Ridaura et al., 2013). In addition, aberrations of intestinal microbiota have
been shown to be associated with the serum metabolome and may contribute to insulin
resistance in non-diabetic subjects (Pedersen et al., 2016).
Initial studies suggested that obesity could be associated with an increased relative
abundance of Firmicutes and decreased levels of Bacteroidetes (Furet et al., 2010; Ley et al.,
2006). However, more recent studies have reported results ranged from an increase in total
diversity to absence of change and even decrease in alpha-diversity (Damms-Machado et
al., 2015; Louis et al., 2016; Patil et al., 2012). These may be explained by differences in diet,
host genotype and physiology and the presence of comorbidities, such as type 2 diabetes
(T2D) (Remely et al., 2016). Moreover, these studies addressed the number and not the
activity of these bacterial phyla. A more recent study addressing the fecal metaproteome
showed that bacteria belonging to the Bacteroidetes were less abundant, but metabolically
much more active in morbidly obese versus non-obese subjects (Kolmeder et al., 2015).
In patients with morbid obesity bariatric surgery is currently the only effective treatment
with long-term results of sustainable weight loss and remission or amelioration of
obesity-related comorbidities (Adams et al., 2017; Puzziferri et al., 2014; Schauer et al.,
2017; Sjostrom, 2013) The underlying mechanisms behind the surgically induced weight
loss have not been fully elucidated. However, reduced food ingestion, increased satiety,
increased gastric emptying and shift in bile acid metabolism have been suggested to
have a role (Laferrere et al., 2008; Plum et al., 2011). In addition, increased diversity and
changes in community composition of the intestinal microbiota have been reported after
bariatric surgery, thus suggesting that some of its beneficial effects may be mediated by
intestinal microbiota (Damms-Machado et al., 2015; Graessler et al., 2014; Palleja et al.,
2016). Previously published studies on the effect of bariatric surgery on fecal microbiota
are not consistent and suggest contradictory results concerning changes in fecal microbiota
diversity after the surgery and between different surgery types (Lee et al., 2019; Paganelli et
al., 2019; Sanchez-Alcoholado et al., 2019). The objective of this study was to characterize
the microbiota of morbidly obese women and to evaluate the impact of bariatric surgery
on microbiota composition.
STUDY SUBJECTS AND METHODS
Study population
Morbidly obese study subjects were recruited from patients undergoing bariatric surgery
procedure as part of their normal treatment at the Hospital District of Southwest Finland
(Dadson et al., 2017; Koffert et al., 2018). The surgical inclusion criteria were age between
18–60 years and BMI ≥40 kg/m2 (or ≥35 kg/m2 with an additional obesity-related
comorbidity). In addition to standard exclusion criteria for bariatric surgery patients with
T2D requiring insulin treatment were excluded. Healthy study subjects were recruited to
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Figure 1 Study flowchart. (A) Healthy study subjects. (B). Obese study subjects.
Full-size DOI: 10.7717/peerj.10442/fig-1
study protocol by advertisements in local newspaper from January to December in 2011.
The inclusion criteria for the control population were body-mass index 18–27 kg m2, age
18–60 years, fasting plasma glucose less than 6.1 mM, and normal oral glucose tolerance
test. Altogether 42 females were recruited for the study, including 27 obese subjects and
15 controls. For nine obese subjects, one of the time points was discarded due to the
inability to PCR amplify the extracted DNA or low reproducibility of the phylogenetic
microarray results (see below). Moreover, three obese subjects withdrew from the study
for personal reasons, and further two subjects who had a successful microbiota profile
only from a single time point were discarded. This yielded the final data set with 13 obese
subjects who had successful microbiota profiles from both time points and 14 controls that
were included in the analysis (Fig. 1). Of the 13 obese subjects, five had T2D and in eight
had normal glycaemia. Only three study subjects with type 2 diabetes were on metformin
medication. Written informed consents were obtained prior the studies. The protocol
(NCT01373892/SLEEVEPET) was approved by the Ethics Committee of the Hospital
District of Southwest Finland (ETMK 99/180/2010). The clinical study was performed at
the Turku PET Centre, the University of Turku and Turku University Hospital (Turku,
Finland) between January 2011 and October 2013 and fecal microbiota samples analyzed
in 2014.
Study design
At screening visit, study subjects gave their signed approvement prior to their enrolment in
to the study. The medical history was recorded, the physical examination, anthropometric
measurements, blood and oral glucose tolerance tests were performed, and instructions
for fecal sample collection were provided. On a separate study visit abdominal fat masses
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were assessed with MRI. Thereafter, obese subjects followed a very low-calorie diet (VLCD;
800kcal/day) for one month before the bariatric operation. Of the morbidly obese subjects,
seven underwent sleeve gastrectomy and six Roux-en-Y gastric bypass (RYGB) surgery.
All the morbidly obese study subjects received perioperative antibiotic Cefuroxime 3g
intravenously. The post-operational phase was conducted six months after the surgery and
all studies were repeated as in baseline. Food diaries were used to document dietary intake
in healthy controls and before the VLCD and 6 months postoperatively in obese subject.
Fecal sample collection and microbiota profiling
Fecal samples for the controls were collected in a single time point and for the obese
subjects both before the VLCD (one month before the surgery) and six months after
the surgery. DNA from fecal samples was extracted with repeated bead-beating as
described previously (Nylund et al., 2010) and used for phylogenetic profiling with the
Human Intestinal Tract (HIT) Chip, a custom-made Agilent phylogenetic microarray
(Rajilic-Stojanovic et al., 2009). The HITChip analysis allows phylotype-level profiling
at a resolution of ∼0.1% relative abundance with >98% reproducibility (Claesson et al.,
2009) based on >5,000 probes designed to target 16S rRNA gene sequences of over
1,000 intestinal bacterial phylotypes from 130 genus-like groups (defined by >90%
16S rRNA gene similarity). Further details on the sample processing, microarray, and
hybridization protocols were reported previously (Rajilic-Stojanovic et al., 2009). The
microarray hybridization data was extracted from scanned microarray images with the
Agilent Feature Extraction software. The technical replicates were quantile-normalized
with custom R scripts as previously described (Lahti et al., 2014), and reproducible
hybridizations (Pearson r > 98%) were accepted for the analysis and stored in a custom
MySQL database. Between-sample normalization was performed at probe level with the
minimum–maximum method, and probe summarization at the phylotype-level (>98%
16S rRNA sequence similarity) was done with the frozen Robust Probabilistic Averaging
(fRPA) method (Lahti et al., 2011; Lahti et al., 2013) and then to the genus (>90% 16S
rRNA sequence similarity) and order-like 16S rRNA gene sequence groups by summing
up phylotype abundances as described earlier (Lahti et al., 2014).The processing scripts are
available at https://github.com/microbiome/HITChipDB. In this work, we focus primarily
on genus-level variation.
Statistical analysis
The HITChip profiles were centered log-ratio transformation (CLR)-transformed before
statistical testing to remove compositionality bias (Aitchison, 1986), and Euclidean distances
for the CLR-transformed genus-level abundances were used as the beta diversity measure.
For hierarchical clustering, we used complete linkage with Spearman correlation. The
surgery effect on individual taxa between the matched obese subject time points 1–2 was
quantified with a random effects linear model with subject as the random effect and time
as the fixed effect (lmer R package). Unpaired t -test was used for two-group comparisons.
Multi-group comparisons were performed with ANOVA and the Tukey post-hoc test. In
order to reduce multiple testing, we removed from comparisons the rare taxa that were
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observed with <10% prevalence at >0.1% relative abundance. To further support the
analysis, we verified the multi-group comparisons with non-parametric Kruskal-Wallis
test and diagnostic plots. PERMANOVA (adonis in the vegan R package) was used
for the group-wise community comparisons. The p-values were adjusted for multiple
corrections with Benjamini–Hochberg method. The FDR<0.05 was considered statistically
significant, and FDR<0.25 borderline significant. Spearman correlation of the probe-level
HITChip signals were used for subject identification based on best match between the
two timepoints. Microbiota richness and diversity were quantified from the probe-level
HITChip data by observed probe count and Shannon index, respectively. Tools from the
phyloseq (McMurdie & S, 2013) andmicrobiome (https://microbiome.github.io/tutorials/)
R packages were used to support analysis and visualization.
Sample size for original study protocol in PET-imaging was determined by joint a priori
power analysis based on longitudinal PET studies using 18F-FTHA (Karmi et al., 2010;
Viljanen et al., 2009) which suggested that a sample size of 10+10 would be sufficient for
establishing the predicted effects at P<0.05 with actual power exceeding 0.95. These study
subjects were used for intestinal microbiota analysis.
RESULTS
Effect of bariatric surgery on glucose metabolism
Before surgery, the obese study group was insulin resistant and had increased systemic
inflammation compared to healthy controls (Table 1). In addition, the obese study subjects
had higher HbA1c and 2-hour glucose concentrations in OGTT compared to healthy
controls (Table 1). Bariatric surgery resulted in marked weight loss (on average 23%) with
improved insulin resistance (Table 1). Furthermore, diabetes remission occurred in 80%
(4/5) of the T2D subjects after surgery.
Dietary intake preceding and after surgery
Mean caloric intake was lower in obese subjects compared to healthy controls but the
difference was only marginally significant (1,304 ± 570 kcal vs. 1,625 ± 518, p= 0.07,
respectively). The total calorie intake decreased in obese subject by 35% on average after
bariatric surgery (p< 0.01).Nutrient intakewas lower postoperatively, while carbohydrate-,
protein- and fat-intake decreased on average by 27% (p< 0.01), 18% (p< 0.01) and 6%
(p= 0.04) respectively.
Control subjects form two distinct groups
Unsupervised hierarchical clustering of the genus-level profiles indicated two distinct
subgroups among the control subjects (Fig. S1). These included 4 normal-weight control
subjects with mean BMI 24.9 kg/m2 (group A) and 10 ‘‘lean’’ control subjects with a lower
average BMI of 21.5 kg/m2 (group B). Differences in body fat and energy consumption
were not significant. The group A controls had on average higher levels of bacteria related
to Allistipes. In contrast, the group B controls had on average higher levels of bacteria
belonging to Ruminococcus obeum, Coprococcus eutactus and Clostridium nexile (p< 0.25).
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Sex (female/male) 14/0 13/0
Age (years) 44± 10 43± 11 0,88 44± 10
Weight (kg) 62± 7.3 113± 17* <0.01 86± 14
BMI (kg m-2) 22.8± 2.9 40.9± 4.2* <0.01 31.4± 3.6*
Body fat (%) 32± 5.8 49± 5.4* <0.01 41± 3.7
FFA (mM) 0.50± 0.20 0.73± 0.29* 0.62 0.78± 0.24*
Fasting glucose (mM) 5.3± 0.6 6.0± 1.1 0.11 5.4± 0.9
Fasting insulin (mU L-1) 5.6± 3.6 11.0± 7.9* 0.19 7.6± 5.0
OGTT 2 h glucose (mM) 5.6± 1.2 8.7± 2.8* <0.01 4.8± 2.0
T2D (n) 0 5 1
uCRP (mg*l-1) 0.8± 1.0 2.9± 2.5* 0.013 0.9± 1.0
HbA1c (%) 5.6± 0.3 5.8± 0.7 0.01 5.3± 0.5
HOMAIR (fraction) 1.1± 0.9 3.1± 2.7* 0.18 1.9± 1.5
Notes.
HOMAIR, homeostatic model assessment for insulin resistance; FFF, free fatty acids; OGTT, oral glucose tolerance test;
T2D, type 2 diabetes.
*p< 0.05 for obese patients pre- and postintervention when compared to controls in Student’s t -test.
Surgery type has no effect on microbiota composition
No differences were observed between the alternative surgery procedures (bypass n= 6;
sleeve n= 7) in post-surgery samples in community composition quantified by the overall
beta diversity or individual genus-like groups (Fig. S2A). These groups were combined in
the subsequent microbiota analyses.
Microbial richness shifts towards controls in patients following surgery
Before surgery, the average richness was significantly lower in the obese subjects compared
to the group A controls (p= 0.01) and borderline significant compared to the group B
controls (p= 0.12) (Fig. 2). After the surgery, the difference to group A controls was
borderline significant (p= 0.14), and difference to the group B controls was not significant
(p= 0.87).
Microbiota community structure shows changes following bariatric
surgery
Bariatric surgery was associated with a shift in the Bacteroidetes-Firmicutes ratio towards
that of the control subjects (Fig. 2B). The overall differences in microbiota composition
(beta diversity) between the obese and control subjects were not significant after the surgery.
Notably, whereas the average abundance of Firmicutes decreased after surgery, specific
members of the Firmicutes exhibited qualitatively different increasing shifts following
the surgery (Fig. 3), indicating that the phylum-level comparison of the Bacteroidetes-
Firmicutes ratio should be complemented by the analysis of specific members within these
groups.
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Figure 2 Microbiota richness in the obese and control groups. (A) The group-wise differences are sig-
nificant for richness (p = 0.01), and borderline significant for diversity (p = 0.22). At the baseline time
point (before surgery), the richness was lower in the obese subjects compared to the normal-weight con-
trols (p= 0.01) and lean controls (borderline significant; p= 0.12). After the surgery, microbiota richness
in the obese reached similar levels with the lean controls (p = 0.87) but remained somewhat lower com-
pared to the normal-weight controls (p = 0.14). (B) The surgery was associated with a significant shift in
the Bacteroidetes-Firmicutes ratio (p= 0.04), whereas the other differences were not significant.
Full-size DOI: 10.7717/peerj.10442/fig-2
Genus-level shifts following the surgery
At the level of specific bacterial genera, bariatric surgery was associated with an increased
abundance of specific members of bacteria belonging to the Bacteroidetes, Streptocooccus
spp. (S. mitis and S. bovis.), as well as Sporobacter termitidis (Clostridium cluster IV) (Fig. 4),
so that the abundances of these bacteria were shifting towards the group A controls. The
observed shift towards these controls was evident also as a reduced abundance in specific
members of the Clostridium cluster XIVa (including bacteria related to Ruminococcus
obeum, Coprococcus eutactus, and other Clostridium groups) after surgery.
Individuality of microbiota composition
Microbial composition remained individual-specific and identifiable following surgery
for most (11/14; 79%) subjects based on the closest match with the pre-surgery samples
(see Methods). However, three subjects experienced so remarkable changes during the
intervention that reliable subject identification based on microbiota composition was not
possible after the surgery (best match was with a sample from another subject; Fig. S3).
However, for two of these incorrectly identified subjects, the second best match was with
the correct subject. For the third misidentified obese subject, his/her own pre-surgery
sample was only the 9th best match, suggesting drastically altered microbiota composition
or potential shift in community type following the surgery.
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Figure 3 Community similarity before and after bariatric. Sample ordination by genus-level commu-
nity composition illustrates a significant shift from obese microbiota (red) towards group A control group
(dark blue) following surgery (p < 0.05). The lower panel shows the ten most strongly associated genus-
like groups for each ordination axis, indicating that surgery is, on average, associated with a reduction of
genera from the Clostridium cluster XIVa and Proteobacteria groups, and an increase in Bacteroidetes,
Clostridium cluster IV, and uncultured Clostridiales. For targeted analysis of changes in genus-level groups
following surgery, see Fig. S2B.
Full-size DOI: 10.7717/peerj.10442/fig-3
Effect of diabetes status
In addition, the microbiota characteristics of metformin-treated obese subjects (n= 3)
and obese subjects with no metformin treatment (n= 10) were compared at the baseline
time point. Diabetes status did not have a statistically significant effect on the overall
microbiota composition as quantified by the standard permutation analysis of variance
(PERMANOVA; p= 0.28).However,metforminwas associatedwith a significant reduction
in intestinal microbiota diversity (p= 0.02; Fig. 5). A similar non-significant trend is seen
in microbiota richness (p= 0.21).
DISCUSSION
In this study, the intestinal microbiota composition of morbidly obese females with and
without T2D and the effects of bariatric surgery inducedweight loss on intestinalmicrobiota
composition and diversity were evaluated. The effect of bariatric procedure on microbiota
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Figure 4 Genus-level microbiota signatures among the study subjects. Abundance variation in the
genus-level groups that exhibited significant changes following the surgery. Z-transformed log10 relative
abundances (HITChip signal) are shown for each genus. The color code indicates increased (red) or de-
creased (blue) abundance compared to the overall mean abundance of the genus across all samples.
Full-size DOI: 10.7717/peerj.10442/fig-4
Figure 5 Metformin treatment andmicrobiota diversity.Metformin treatment is associated with re-
duced microbiota diversity (p= 0.02).
Full-size DOI: 10.7717/peerj.10442/fig-5
signatures was characterized by increased microbiota richness, increased abundance of
facultative anaerobes and decreased abundances of specific butyrate-producing Firmicutes.
Before bariatric surgery, the overall microbiota composition of the morbidly obese
subjects was closer to the group B controls than group A controls. This potentially reflects
the effect of calorie-restricted weight-loss diet in the obese group (Cotillard et al., 2013) as
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the patients undergoing bariatric surgery in Finland are required to lose approximately 5%
of their weight before surgery. Six months after the operation, microbiota composition
of the obese subjects had shifted towards the group A controls (Fig. 3). These shifts were
observed both in the overall community composition (beta diversity), in specific genera,
community richness and in Bacteroidetes-Firmicutes ratio. Despite the shifts observed,
microbial composition remained individual-specific and identifiable following surgery
for the most which is in line with current literature (Durack & Lynch, 2019; Healey et al.,
2017). In a recent study conducted by Paganelli and her colleagues low-calorie diet and
bariatric surgery per se only temporary declined fecal microbiota diversity and gradually
these changes returned to baseline levels in six months (Paganelli et al., 2019). On the other
hand, Lee’s research group documented increase in fecal microbiota diversity after the
RYGB and drug-induced weight loss (Lee et al., 2019). All of these studies are limited by
low number of study subjects and shortage of male study subjects in different intervention
groups.
In previous studies, subjects with prediabetes or overt T2D have been reported to have
a distinct microbiota profile compared to non-diabetic subjects (Allin et al., 2018; Qin
et al., 2012). In current study, we did not observe differences in microbiota signatures
related to the diabetic status at the baseline (p= 0.048). However, microbiota diversity
was significantly decreased in metformin—treated diabetic subjects compared to diabetic
subjects without medication (Fig. 5). This finding is in contrast to recent study by Forslund
and colleagues, where decreased bacterial richness was detected among metformin-naive
individuals with type 2 diabetes when compared to individuals treated with metformin
(Forslund et al., 2015).
Increased relative abundances of facultative anaerobic microbes, such as Streptococcus
spp. and Allistipes et rel. were observed after bariatric surgery. This is in line with previous
studies reporting increased relative abundances of facultative anaerobic microbes from
upper gastrointestinal tract (such as Streptococcus, Veillonella and Escherichia spp.) after
bariatric surgery (Ilhan et al., 2017; Palleja et al., 2016). Paganelli’s research group showed
that after the VLCD relative abundance of Streptococcae was decreased but the abundance
gradually increased one week after the operation and these changes persisted even 6
months after the operation(Paganelli et al., 2019). These changes most likely reflect the
changed anatomy of gastrointestinal tract and decreased exposure to gastric acids after
operation. Postoperative microbiota changes observed here might reflect the microbiota
adaptation to changing conditions in the gastrointestinal tract and energy restriction as
well as infeasibilities of fiber-rich foods after bariatric surgery as shown by the increase
in Bacteroidetes/Firmicutes ratio and by the reduced abundance of butyrate-producing
bacteria. Moreover, a diet rich in resistant starch may not be tolerated after the bariatric
surgery. Indeed, a reduction of one of the colonic starch degrading Ruminococcus obeum
-related bacteria was observed in post-operative microbiota. Based on studies with dietary
interventions for weight loss, restrictive diets seem to promote a reduction in intestinal
microbiota diversity and a reduction in certain bacterial groups, such as butyrate-producing
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Firmicutes, Clostridium spp. Lactobacillus spp. and Bifidobacterium spp. (Damms-Machado
et al., 2015; Graessler et al., 2014; Palleja et al., 2016). These changes seem to correlate to a
reduction in the intake of complex carbohydrates rather than to a weight loss as such.
Given the fact that bariatric surgery rearranges the gut microbiota, it is worth noting
the role of potential modulators of intestinal microbiota, such as prebiotics and synbiotics.
In the study of Fernandes’s research group oral administration of a prebiotic (fructo-
oligosaccharide) after RYGB promoted significant reduction in body weight, whereas
both prebiotic and synbiotic supplements were not sufficient to promote significant
improvement in the inflammatory markers (Fernandes et al., 2016). Unfortunately, this
study lacks the data of change in fecal microbiota. Since bariatric surgery has shown to
induce intestinal bacterial overgrowth, Woodard et al. randomized 44 patients undergoing
RYGB to placebo or 2.4 billion colonies of Lactobasillus. This probiotic administration
improved bacterial overgrowth, vitamin B12 availability, and weight loss after RNYGB
(Woodard et al., 2009). Based on these findings further investigation in pre- and synbiotics
with larger sample size and fecal microbiota sampling is warranted in the future.
During this study, we observed two distinct groups of control subjects with a distinct
microbiota composition as well as differences in body-mass index and other host
parameters. These groups were not included in the original study design, and hence
the findings relating to the distinct control groups in this study are exploratory and limited
in sample size. This observation highlights the microbiota signatures as an essential host
feature that should be considered already in the study design. These findings should be
further verified in an independent study.
There are some limitations in this study. First, study groups were small and while
the findings are in line with current literature further research with larger cohorts is
warranted. Second, only female subjects were studied, and thus the findings may not be
generalized to males. Third, fecal samples were collected in surgery group only before
the low-calorie diet and 6 months after the operation. Therefore, we can’t rule out that
part of the microbiota changes was induced by presurgery diet. Fourth, HITChip is based
on cross-hybridization of the complementary 16S rRNA sequences, and may therefore
include noise from related sequences, and potential misclassifications between closely
related species. For this reason, we have restricted the analysis on genus-level profiles.
The other shortcoming of phylogenetic microarrays is that they quantify only the known
community members that have been included on the microarray design. The HITChip has
been designed to capture all major bacterial groups that have been reported in human gut
microbiome; it may miss some rare groups that have low abundance and low population
prevalence. On the other hand, this platform is standardized, highly reproducible, and cost
efficient compared to sequencing depths that can reach the same sensitivity.
CONCLUSION
The intestinal microbiota composition of morbidly obese subjects shifted towards group
A (‘‘normal weight’’) controls within six months after the bariatric surgery. This shift was
detectable in the overall community composition, richness, Bacteroidetes/Firmicutes ratio,
Koffert et al. (2020), PeerJ, DOI 10.7717/peerj.10442 11/18
as well as in abundances of specific bacterial genera. However, the individuality of the
microbiota community composition was preserved in most cases so that the microbiota
profiles could be used to identify individuals before and after surgery. In addition, we
observed that the control subjects clustered in two broad groups with a distinct microbiota
composition characterized by differences in particular in Bacteroides, whose abundance
was on average higher in the group A controls than in group B subjects (‘‘lean’’ controls).
Hence, broad community types might be an essential feature to include in the original
study design in future studies.
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